Theravance eyes June 2 split into drug, royalties companies

Theravance Inc. will split into two companies — one sucking up the royalties from its partnership with GlaxoSmithKline, the other focused on drug development — on June 2, the company said Tuesday...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.